Results from its collaborative work with Pfizer to develop a potent and orally bioavailable macrocycle modulator have been published [...]
David Spellmeyer, PhD, has been appointed as Circle Pharma's chief scientific officer [...]
An expansion of Series A financing has been completed, with new investors W.I. Harper Group, [...]
Series A financing round has been announced in which over $4.5M of shares have been issued [...]
Designing and creating a physical screening library of novel macrocyclicpeptides [...]
Co-founder Prof. M. Jacobson has been appointed Chair of the UCSF Department of Pharm. Chemistry [...]
The seed funding round has been extended with an investment from ShangPharma Investment Group [...]
Circle Pharma has received seed funding from Pfizer Inc. and QB3’s seed-stage venture fund, Mission Bay Capital, LLC, and has initiated two collaborations with Pfizer [...]